IGF1 and chronic kidney disease: Earlier work by Wang et al. (2009) has demonstrated that mice with CKD have blunted insulin/insulin like growth factor 1 (IGF-1) signaling which centers around a reduced phosphorylation of Akt in these animals and which ultimately results in muscle atrophy that is commonly seen in CKD.